ADIPOQ and neoplasm: Given the previous reports that the plasma levels of adiponectin and leptin are differentially modulated in obese patients and these adipokines often show opposites activities on tumor development [59], the findings of this study suggest that differential regulation of inflammasomes activation by adiponectin and leptin could be a potential mechanism underlying the contrasting effects of these adipokines.